DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)
South Korea · Delayed Price · Currency is KRW 9,930.00
-110.00 (-1.10%)
At close: Oct 23, 2026
DAE HWA Pharmaceutical Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 148,754 | 143,060 | 149,409 | 141,359 | 131,912 | 117,159 |
Revenue Growth | 0.14% | -4.25% | 5.70% | 7.16% | 12.59% | 7.14% |
Gross Profit Gross Profit Growth | 51,479 | 46,939 | 52,212 | 44,661 | 45,614 | 43,252 |
Operating Income Operating Income Growth | 5,531 | 3,162 | 6,712 | 1,962 | 5,847 | 3,284 |
Net Income Net Income Growth | 4,434 | 1,654 | 531.42 | -1,147 | 1,116 | 2,217 |
Earnings Per Share EPS Growth | 248.12 | 94.33 | 30.34 | -65.47 | 63.69 | 126.59 |
EPS Growth | 566.27% | 210.93% | - | - | -49.69% | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Pharmaceutical Manufacturing Industry Pharmaceutical Manufacturing Industry Growth | 113,400 | 105,285 | 113,503 | 105,146 | 99,192 | 88,705 |
Pharmaceutical Wholesale Business Pharmaceutical Wholesale Business Growth | 24,191 | 24,264 | 22,395 | 22,548 | 23,626 | 20,919 |
Medical Information System Medical Information System Growth | 424.23 | 285.82 | 303.72 | 285.59 | 352.03 | 386.76 |
Pharmaceutical Raw Materials Manufacturing Pharmaceutical Raw Materials Manufacturing Growth | 14,651 | 17,835 | 17,149 | 14,611 | 13,805 | 10,073 |
Cosmetic and medical device manufacturing and sales Cosmetic and medical device manufacturing and sales Growth | 8,475 | 7,904 | 11,099 | 9,807 | 8,992 | 7,049 |
Unallocated Adjustment Unallocated Adjustment Growth | -12,388 | -12,514 | -15,039 | -11,038 | -14,056 | -9,973 |
Total Total Growth | 148,754 | 143,060 | 149,409 | 141,359 | 131,912 | 117,159 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 7,553 | 6,102 | 7,863 | 13,458 | 7,962 | 18,422 |
Total Debt Total Debt Growth | 101,956 | 96,776 | 99,274 | 110,525 | 90,066 | 70,150 |
Net Cash (Debt) Net Cash Growth | -94,403 | -90,674 | -91,411 | -97,067 | -82,104 | -51,728 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -5282.91 | -5172.72 | -5218.53 | -5541.39 | -4687.19 | -2953.08 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -340.14 | 5,428 | 5,250 | -214.41 | 8,193 | 10,386 |
Capital Expenditures CapEx Growth | -2,161 | -2,836 | -4,374 | -8,907 | -27,690 | -9,684 |
Free Cash Flow Free Cash Flow Growth | -2,501 | 2,591 | 875.3 | -9,122 | -19,497 | 701.81 |
Free Cash Flow Growth | - | 196.06% | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 34.61% | 32.81% | 34.95% | 31.59% | 34.58% | 36.92% |
Operating Margin | 3.72% | 2.21% | 4.49% | 1.39% | 4.43% | 2.80% |
Pretax Margin | 5.22% | 3.34% | 1.01% | -0.32% | 1.84% | 3.86% |
Profit Margin | 2.98% | 1.16% | 0.36% | -0.81% | 0.85% | 1.89% |
FCF Margin | -1.68% | 1.81% | 0.59% | -6.45% | -14.78% | 0.60% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 150.000 | 150.000 | 150.000 | 150.000 | 150.000 | 150.000 |
Dividend Per Share Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Dividend Yield | 1.51% | 0.87% | 1.37% | 1.60% | 1.60% | 1.61% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 40.02 | 184.65 | 360.61 | - | 147.59 | 73.63 |
P/FCF Ratio | - | 117.82 | 218.93 | - | - | 232.62 |
PS Ratio | 1.23 | 2.13 | 1.28 | 1.16 | 1.25 | 1.39 |